4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-030214
Director acquired 77,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PERRY MICHAEL S · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-14 | Exercise or conversion : show line 1 in the form | +7,000 | $4.75 | $33,250 | 15,000 | D |
| 2020-05-14 | Exercise or conversion : show line 2 in the form | +5,000 | $2.01 | $10,050 | 20,000 | D |
| 2020-05-14 | Exercise or conversion : show line 3 in the form | +15,000 | $2.19 | $32,850 | 35,000 | D |
| 2020-05-14 | Exercise or conversion : show line 4 in the form | +10,000 | $2.62 | $26,200 | 45,000 | D |
| 2020-05-14 | Exercise or conversion : show line 5 in the form | +15,000 | $5.19 | $77,850 | 60,000 | D |
| 2020-05-14 | Exercise or conversion : show line 6 in the form | +25,000 | $4.20 | $105,000 | 85,000 | D |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-14 | Exercise or conversion : show line 7 in the form Common Stock (right to buy) | −7,000 | 70,000 | D |
| 2020-05-14 | Exercise or conversion : show line 8 in the form Common Stock (right to buy) | −5,000 | 65,000 | D |
| 2020-05-14 | Exercise or conversion : show line 9 in the form Common Stock (right to buy) | −15,000 | 50,000 | D |
| 2020-05-14 | Exercise or conversion : show line 10 in the form Common Stock (right to buy) | −10,000 | 40,000 | D |
| 2020-05-14 | Exercise or conversion : show line 11 in the form Common Stock (right to buy) | −15,000 | 25,000 | D |
| 2020-05-14 | Exercise or conversion : show line 12 in the form Common Stock (right to buy) | −25,000 | 0 | D |
Loading xslF345X03/doc4.xml…